Cargando…
Topical administration of adrenergic receptor pharmaceutics and nerve growth factor
Topical application of nerve growth factor (NGF) and adrenergic receptor pharmaceutics are currently in use for corneal ulcers and glaucoma. A recent interest in the neuroprotective abilities of NGF has led to a renewed interest in NGF as a therapeutic for retinal and choroidal diseases. NGF can pro...
Autor principal: | Steinle, Jena J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909889/ https://www.ncbi.nlm.nih.gov/pubmed/20668722 |
Ejemplares similares
-
Etanercept restores normal insulin signal transduction in β2-adrenergic receptor knockout mice
por: Jiang, Youde, et al.
Publicado: (2014) -
β1-adrenergic receptor stimulation by agonist Compound 49b restores insulin receptor signal transduction in vivo
por: Jiang, Youde, et al.
Publicado: (2014) -
β2-Adrenergic Receptor Knockout Mice Exhibit A Diabetic Retinopathy Phenotype
por: Jiang, Youde, et al.
Publicado: (2013) -
Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the β(1)-adrenergic receptor knockout mouse
por: Panjala, Surekha Rani, et al.
Publicado: (2011) -
The Potential of Pharmaceutical Hydrogels in the Formulation of Topical Administration Hormone Drugs
por: Ostróżka-Cieślik, Aneta
Publicado: (2022)